中国生物工程杂志

［1］ Williams D A，Baum C. Medicine gene therapynew challenges ahead. Science，2003，302(5644)：400401. 
［2］ Kaiser J. Gene therapyputting the fingers on gene repair. Science，2005，310(5756)：18941896. 
［3］ Kostarelos K，Miller A D. Synthetic，selfassembly ABCD nanoparticles； a structural paradigm for viable synthetic nonviral vectors. Chem Soc Rev， 2005，34(11)：970994. 
［4］ Enrico M，Wim E. Artificial viruses：a nanotechnological approach to gene delivery. Nature Reviews，2006，5(2)：115121. 
［5］ Kogure K， Akita H，Harashima H. Multifunctional envelopetype nano device for nonviral gene delivery：concept and application of programmed packaging. J Control Release，2007，122(3)：246251. 
［6］ Kogure K，Akita H，Harashima H. Programmed packaging：a new drug delivery system and its application to gene therapy.In:Knablein J. Modern Biopharmaceuticals.Weinheim:WileyVCH,2008.15211536. 
［7］ Kogure K，Akita H，Harashima H. Multifunctional envelopetype nano device (MEND) as a nonviral gene delivery system. Adv Drug Deliv Rev，2008，60(45)：559571. 
［8］ Kogure K，Moriguchi R，Harashima H. Development of a nonviral multifunctional envelopetype nano device by a novel lipid film hydration method. J Controlled Release，2004，98(2)：317323. 
［9］ 叶杰胜，张娜，马春红，等. 载鱼精蛋白pDNA复合物固体脂质纳米粒的初步研究.中国药学杂志，2007，42(21)：16441688. Ye J S，Zhang N，Ma C H，et al. Chin Pharm J，2007，42(21)：16441688. 
［10］ 张建华，高秉仁，李斌，等. 纳米基因载体的研究进展.微创医学，2007，2(2)：125127. Zhang J H，Gao B R，Li B，et al. Minimally Invasive Medicine，2007，2(2)：125127. 
［11］ 朱传龙，宁琴. 基因治疗中非病毒载体的研究进展.国外医学遗传学分册，2004，27(4)：210213. Zhu C L，Ming Q. Section Genet Foreign Med Sci，2004，27(4)：210213. 
［12］ Moriguchi R，Kogure K，Harashima H. A multifunctional envelopetype nano device for novel gene delivery of siRNA plasmids. Journal of Pharmaceutics，2005，301(1)：277285. 
［13］ Khalil I A，Kogure K，Harashima H. High density of octaarginine stimulates macropinocytosis leading to ef?cient intracellular traf?cking for gene expression. J Biol Chem，2006，281(6)：35443551. 
［14］ Rumiko M，Kentaro K Harashima. Nonlinear pharmacodynamics in a nonviral gene delivery system：Positive nonlinear relationship between dose and transfection efficiency. J Controlled Release，2006，110(3)：605609. 
［15］ Khalil I A，Kogure K，Futaki S，et al. Octaargininemodified multifunctional envelopetype nanoparticles for gene delivery. Gene Ther，2007，14(8)：682689. 
［16］ ElSayed A，Masuda T，Harashima H. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. J Control Release，2009，138(2)：160167. 
［17］ Mudhakir D，Akita H，Harashima H. A novel IRQ ligandmodified nanocarrier targeted to a unique pathway of caveolar endocytic pathway. J Control Release，2008，125(2)：164173. 
［18］ Tandia B M，Vandenbranden M，Elouahabi A. Identi?cation of human plasmaproteins that bind to cationic lipid/DNA complex and analysis of their effects on transfection efficiency：implications for intravenous gene transfer. Mol Ther，2003，8(2)：264273. 
［19］ Hatakeyama H，Akita H，Harashima1 H. Development of a novel systemic gene delivery system for cancer therapy with a tumorspecific cleavable PEGlipid. Gene Therapy，2007，14(1)：6877. 
［20］ Kakudo T，Chaki S，Harashima H. Transferrinmodified liposomes equipped with a pHsensitive fusogenic peptide：an artificial virallike delivery system. Biochemistry，2004，43(19)：56185620. 
［21］ Hatakeyama H，Itho E，Harashima H. A pHsensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNAcontaining nanoparticles in vitro and in vivo. J Control Release，2009，139(2)：127132. 
［22］ Sakurai Y，Hiroto H，Hideyoshi H. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine，GALA and tumorspecific，cleavable polyethylene glycol system. Biol Pharm Bull，2009，32(5)：928932. 
［23］ Higashi T，Akita H，Harashima H，et al. Novel lipidated sorbitolbased molecular transporters for nonviral gene delivery. J Control Release，2009，136(2)：140147. 
［24］ Nakamura Y，Kogure K，Futaki S，et al. Octaargininemodified multifunctional envelopetype nano device for siRNA. J Control Release，2007，119(3)：360367. 
［25］ Moriguchi R，Kogur K，Harashim H，et al. A multifunctional envelopetype nano device for novel gene delivery of siRNA plasmids. Int J Pharm，2005，301(1)：277285. 
［26］ Yamada Y，Kogure K，Harashima H. Development of efficient packaging method of oligodeoxynucleotides by a condensed nanoparticle in lipid envelope structure. Biol Pharm Bull，2005，28(10)：19391942. 
［27］ Nakamura Y，Kogure K，Harashima H，et al. Significant and prolonged antisense effect of a multifunctional envelopetype nano device encapsulating antisense oligodeoxynucleotide. J Pharm Pharmacol，2006，58(4)：431437. 
［28］ Li L Hoffman R M. The feasibility of targeted selective gene therapy of the hair follicle. Nature Medicine，1995，1(7)：705706. 
［29］ Domashenko A，Gupta S，Cotsarelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol，2000，18(4)：420423.